Cape Verde vs Kenya: Hepatitis B surface antigen (HBsAg) prevalence
Cape Verde
0.7%
in 2024
Kenya
0.7%
in 2024
Cape Verde rank
43rd
Kenya rank
43rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cape Verde
- Kenya
How they compare
Cape Verde currently reports 0.7% against 0.7% in Kenya, a difference of 0.0%.
Across all 10 years both countries report, Kenya has been ahead every year.
Cape Verde ranks 43rd and Kenya ranks 43rd of 194 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 1.1% | 0.2% | Kenya |
| 2020s | 0.6% | 0.9% | 0.3% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cape Verde or Kenya?
- Cape Verde, at 0.7% against 0.7% in Kenya as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cape Verde and Kenya?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Kenya?
- 10 years are reported by both, from 2015 to 2024.
- How do Cape Verde and Kenya rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cape Verde ranks 43rd and Kenya ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.